Join
Live feed
·
INSIDERFilingvia Quantisnow
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Brenner Randall B. was granted 47,727 shares and sold $52,157 worth of shares (19,608 units at $2.66) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 349,149 units to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
PRTK· Paratek Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Brenner Randall B. was granted 47,727 shares and sold $52,157 worth of shares (19,608 units at $2.66) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 349,149 units to satisfy withholding tax | Quantisnow